Cavernous sinus thrombosis classification: Difference between revisions
(Created page with "__NOTOC__ {{Cavernous sinus thrombosis}} {{CMG}}; {{AE}} {{MMJ}} ==Overview== There is no established system for the classification of [disease name]. OR [Disease name] may...") |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
By the Jefferson classification, 11% of the 162 patients had the anterior type of lesion, 12% the middle, 8% the posterior type, and 69% the unclassifiable type. However, by the Ishikawa classification, 35% had the anterior type, 10% the middle type, 22% the posterior type, 5% the whole type, and 28% the unclassifiable type of lesion. Furthermore, the Ishikawa classification revealed that the etiology of the anterior type was mainly inflammation, and that the etiology of the posterior and whole types was tumors. | |||
[Disease name] may be classified according to | [Disease name] may be classified according to Jefferson classification into [number] subtypes/groups: [group1], [group2], [group3], and [group4]. | ||
OR | OR | ||
Line 33: | Line 32: | ||
==Classification== | ==Classification== | ||
* The Jefferson classification and Ishikawa classification has been used to localize cavernous sinus lesions. | |||
* According to the the location of the intracranial orifice of the optic canal and the entry of the maxillary nerve into the cavernous sinus, lesions may be classified in Ishikawa classification into three groups: | |||
**Anterior lesions | |||
**Middle lesions | |||
**Posterior lesions | |||
* | |||
* | |||
* | |||
* | |||
OR | OR | ||
Revision as of 15:04, 18 June 2018
Cavernous sinus thrombosis Microchapters |
Differentiating Cavernous sinus thrombosis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Cavernous sinus thrombosis classification On the Web |
American Roentgen Ray Society Images of Cavernous sinus thrombosis classification |
Risk calculators and risk factors for Cavernous sinus thrombosis classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
By the Jefferson classification, 11% of the 162 patients had the anterior type of lesion, 12% the middle, 8% the posterior type, and 69% the unclassifiable type. However, by the Ishikawa classification, 35% had the anterior type, 10% the middle type, 22% the posterior type, 5% the whole type, and 28% the unclassifiable type of lesion. Furthermore, the Ishikawa classification revealed that the etiology of the anterior type was mainly inflammation, and that the etiology of the posterior and whole types was tumors.
[Disease name] may be classified according to Jefferson classification into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
OR
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3]. [Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
OR
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
If the staging system involves specific and characteristic findings and features: According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
The staging of [malignancy name] is based on the [staging system].
OR
There is no established system for the staging of [malignancy name].
Classification
- The Jefferson classification and Ishikawa classification has been used to localize cavernous sinus lesions.
- According to the the location of the intracranial orifice of the optic canal and the entry of the maxillary nerve into the cavernous sinus, lesions may be classified in Ishikawa classification into three groups:
- Anterior lesions
- Middle lesions
- Posterior lesions
OR
[Disease name] may be classified into [large number > 6] subtypes based on:
- [Classification method 1]
- [Classification method 2]
- [Classification method 3]
[Disease name] may be classified into several subtypes based on:
- [Classification method 1]
- [Classification method 2]
- [Classification method 3]
OR
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
If the staging system involves specific and characteristic findings and features:
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
The staging of [malignancy name] is based on the [staging system].
OR
There is no established system for the staging of [malignancy name].